跳至主要内容
临床试验/IRCT20231214060363N1
IRCT20231214060363N1已完成3 期

Evaluation of the effectiveness of Lactogum and Coldanese in preventing flu-like symptoms: A cluster randomized phase 3 clinical trial without blinding.

afs zist Farmed Company0 个研究点目标入组 2,000 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
2,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 70 years(—)
性别
All

入选标准

  • age range was 16 to 70 years old
  • healthcare workers and members of therapeutic Mawkibs

排除标准

  • Severe cardiovascular, endocrinological, respiratory, and gastrointestinal diseases
  • Irritable bowel syndrome, active ulcerative colitis, or short bowel syndrome
  • Known hypersensitivity or allergy to any component of the test products
  • Severe deviation of the nasal septum, presence of nasal polyps, or other non-infectious conditions leading to nasal blockage
  • Recent treatment of the common cold that, in the opinion of the investigator, may influence symptoms
  • Immunodeficiency

研究者

发起方
afs zist Farmed Company

相似试验